Egyesült Királyság - angol - MHRA (Medicines & Healthcare Products Regulatory Agency)

sigma pharmaceuticals plc - nortriptyline hydrochloride - oral tablet - 25mg

Egyesült Királyság - angol - MHRA (Medicines & Healthcare Products Regulatory Agency)

sigma pharmaceuticals plc - amitriptyline hydrochloride - oral tablet - 25mg

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - digoxin, quantity: 250 microgram - tablet, uncoated - excipient ingredients: magnesium stearate; rice starch; lactose monohydrate; oxidised maize starch; hydrolysed maize starch - congestive heart failure - sigmaxin is useful regardless of whether the failure is predominantly of the left or right ventricle, or involves both sides of the heart. it is particularly useful in heart failure resulting from chronic overload (hypertension, valvular lesions, atherosclerotic heart disease) in which the supply of energy is not impaired. sigmaxin does not cause major benefit in situations in which the metabolic energy supply is compromised as in thyrotoxicosis, hypoxia, and severe thiamine deficiency. atrial fibrillation - because sigmaxin depresses conduction in the atrioventricular bundle, producing a slower ventricular beat, it is valuable in atrial fibrillation. it will frequently convert atrial flutter into fibrillation and, upon withdrawal of the drug, normal sinus rhythm may be restored. paroxysmal atrial tachycardia - sigmaxin may relieve or prevent an attack, but its use in paroxysmal ventricular tachycardia is dangerous.

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - digoxin, quantity: 0.0625 microgram - tablet, uncoated - excipient ingredients: lactose monohydrate; rice starch; magnesium stearate; hydrolysed maize starch; povidone; indigo carmine; oxidised maize starch - congestive heart failure - sigmaxin is useful regardless of whether the failure is predominantly of the left or right ventricle, or involves both sides of the heart. it is particularly useful in heart failure resulting from chronic overload (hypertension, valvular lesions, atherosclerotic heart disease) in which the supply of energy is not impaired. sigmaxin does not cause major benefit in situations in which the metabolic energy supply is compromised as in thyrotoxicosis, hypoxia, and severe thiamine deficiency. atrial fibrillation - because sigmaxin depresses conduction in the atrioventricular bundle, producing a slower ventricular beat, it is valuable in atrial fibrillation. it will frequently convert atrial flutter into fibrillation and, upon withdrawal of the drug, normal sinus rhythm may be restored. paroxysmal atrial tachycardia - sigmaxin may relieve or prevent an attack, but its use in paroxysmal ventricular tachycardia is dangerous.

Egyesült Királyság - angol - MHRA (Medicines & Healthcare Products Regulatory Agency)

sigma pharmaceuticals plc - amitriptyline hydrochloride - oral tablet - 10mg

Egyesült Királyság - angol - MHRA (Medicines & Healthcare Products Regulatory Agency)

sigma pharmaceuticals plc - amitriptyline hydrochloride - oral tablet - 50mg

Egyesült Államok - angol - NLM (National Library of Medicine)

rising pharmaceuticals, inc - protriptyline hydrochloride (unii: 44665v00o8) (protriptyline - unii:4ndu154t12) - protriptyline hydrochloride tablets are indicated for the treatment of symptoms of mental depression in patients who are under close medical supervision. its activating properties make it particularly suitable for withdrawn and anergic patients. protriptyline hydrochloride tablets are contraindicated in patients who have shown prior hypersensitivity to it. it should not be given concomitantly with a monoamine oxidase inhibiting compound. hyperpyretic crises, severe convulsions, and deaths have occurred in patients receiving tricyclic antidepressant and monoamine oxidase inhibiting drugs simultaneously. when it is desired to substitute protriptyline for a monoamine oxidase inhibitor, a minimum of 14 days should be allowed to elapse after the latter is discontinued. protriptyline should then be initiated cautiously with gradual increase in dosage until optimum response is achieved. protriptyline is contraindicated in patients taking cisapride because of the possibility of adverse cardiac interaction

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - hydrocortisone acetate, quantity: 10 mg/g - ointment - excipient ingredients: hard paraffin; liquid paraffin; wool fat; white soft paraffin - topical corticosteroid therapy for non-infective inflammatory conditions of the skin eg. eczema, dermatitis.

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - hydrocortisone acetate, quantity: 10 mg/g - cream - excipient ingredients: liquid paraffin; purified water; chlorocresol; cetostearyl alcohol; cetomacrogol 1000; white soft paraffin - topical corticosteroid therapy for non-infective inflammatory conditions of the skin eg. eczema, dermatitis.

Ausztrália - angol - APVMA (Australian Pesticides and Veterinary Medicines Authority)

cromag pty ltd - chlorine present as sodium hypochlorite - liquid - chlorine present as sodium hypochlorite mineral-chlorine active 125.0 g/l - pool chlorine - spa | swimming pool | outdoor spa | spa pools - algae | bacteria